Investor relations
Investor relations news
2025.05.15
2025.05.15
FY2024 Second-Half Results Briefing Session Script
2025.05.15
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data at ASGCT 28th Annual Meeting
2025.05.14
[Delayed]Notice of Recognition of Gain on Deferred Income Taxes
2025.05.13
JCR Pharmaceuticals Announces Chairman and President Transition as of April 1, 2026
2025.05.13
FY2024 Results Briefing Session Material
2025.05.13
Financial Summary Consolidated Financial Results for the Year ended March 31, 2025 (FY2024) (Japanese standard)
2025.05.13
JCR Pharmaceuticals Announces New Corporate Philosophy and Core Values
2025.05.13
Notice of Distribution of Retained Earnings
2025.05.08
JCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy 28th Annual Meeting
Discover our past news and updates, including the latest announcements and historical insights.
Explore past investor relations materials, from reports to presentations.